Treatment of intrahepatic cholangiocarcinoma
10.3760/cma.j.cn115396-20200517-00155
- VernacularTitle:肝内胆管细胞癌的治疗策略研究进展
- Author:
Lei GONG
1
;
Xin HUANG
;
Bin SHU
;
Qijia ZHANG
;
Liang WANG
;
Rui TANG
;
Ying XIAO
;
Canhong XIANG
Author Information
1. 清华大学附属北京清华长庚医院肝胆胰外科 102218
- From:
International Journal of Surgery
2020;47(6):386-391,f3
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma has low resectability rate, high recurrence and short survival. It is very important to formulate and optimize the strategy of surgical treatment. The only potentially effective treatment for intrahepatic cholangiocarcinoma is surgical resection. Liver transplantation also has some application prospects. Intrahepatic cholangiocarcinoma can be divided into four types: mass forming type, intraductal growth type, periductal infiltration type, mass forming + periductal infiltration(mixed)type. Clinically, the treatment strategy is mainly determined according to the general classification. The application of methods such as preoperative portal vein embolism, neoadjuvant therapy and lymph node dissection make it possible for more patients to undergo surgical resection and improve the surgical effect. Adjuvant treatment including chemotherapy and radiotherapy can significantly improve the prognosis of the patients. The rapid development of molecular targeted therapy and immunotherapy is gradually changing the clinical treatment of intrahepatic cholangiocarcinoma.
